| Patents for G01N - Investigating or analysing materials by determining their chemical or physical properties (5,201) |
|---|
| 03/18/2004 | WO2004023104A2 Coated capillary electrophoresis tubes and system |
| 03/18/2004 | WO2004023101A2 Methods of cardiovascular disease assessment in an individual |
| 03/18/2004 | WO2004023098A2 Method for detecting transferase enzymatic activity |
| 03/18/2004 | US20040053333 Identifying hidden patterns associated with serum samples which can be used to generate control models for disease; improving bioassay accuracy |
| 03/18/2004 | US20040053317 Using gene patterns to diagnose and prognose tumor cells |
| 03/18/2004 | US20040053263 Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
| 03/18/2004 | CA2498329A1 Methods of cardiovascular disease assessment in an individual |
| 03/18/2004 | CA2497476A1 Method for detecting atp-dependent transferase enzymatic activity |
| 03/11/2004 | WO2004020981A2 Methods of screening cyclic peptides and identifying targets therefor |
| 03/11/2004 | WO2004020980A2 Assays for the detection of biliverdin in birds and reptiles |
| 03/11/2004 | WO2004020968A2 Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease |
| 03/11/2004 | WO2003064993A3 Methods and materials for detecting genetic material |
| 03/11/2004 | WO2003045218A3 Method for holistic diagnosis and cards for its implementation |
| 03/11/2004 | US20040048241 Electrically coupling an metal electrode pair in a biosensor with a macromolecule; derivatizing with a reactive group, masking and applying voltage |
| 03/11/2004 | US20040045828 Coated capillary electrophoresis tubes and system |
| 03/10/2004 | EP1395939A2 Method and apparatus for feedback controlled electrospray |
| 03/10/2004 | EP1395810A1 Semen analysis |
| 03/09/2004 | US6703606 Neutron burst timing method and system for multiple measurement pulsed neutron formation evaluation |
| 03/04/2004 | WO2004019001A2 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 03/04/2004 | WO2004018999A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 03/04/2004 | WO2004018997A2 Methods and compositions for modulating amyloid beta |
| 03/04/2004 | WO2004018992A2 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |
| 03/04/2004 | WO2003104763A3 Apparatus and method for relative or quantitative comparison of multiple samples |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | CA2496272A1 Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 03/03/2004 | EP1392863A1 Method for determining the presence of extension products |
| 03/03/2004 | CN1140884C Detector for scattered light |
| 02/26/2004 | WO2004017042A2 Methods and reagents for surface functionalization |
| 02/26/2004 | WO2004017039A2 Methods for identifying a prospective binding site on a target molecule and for characterizing a site on a target molecule |
| 02/26/2004 | CA2496141A1 Methods and reagents for surface functionalization |
| 02/25/2004 | EP1390760A2 Assay system |
| 02/25/2004 | EP1390711A2 Patient compliance and monitoring system |
| 02/19/2004 | WO2004015395A2 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | WO2004015394A2 Cancer diagnostics and prognostics |
| 02/19/2004 | WO2004015393A2 Spotting pattern for placement of compounds in an array |
| 02/19/2004 | WO2004015391A2 Mass spectrometry-based identification of proteins |
| 02/19/2004 | WO2004015389A2 Methods of identifying compouds that modulate igg mediated mast cell activation |
| 02/19/2004 | WO2004014220A2 Devices and methods for detecting amniotic fluid in vaginal secretions |
| 02/19/2004 | US20040034481 Computerized drug screening |
| 02/19/2004 | US20040033519 Binary or polynary targeting and uses thereof |
| 02/19/2004 | US20040033517 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (PAR1) |
| 02/19/2004 | US20040033226 Osteopontin, oligodendrocytes and myelination |
| 02/19/2004 | CA2534874A1 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | CA2533915A1 Devices and methods for detecting amniotic fluid in vaginal secretions |
| 02/19/2004 | CA2494928A1 Cancer diagnostics and prognostics |
| 02/18/2004 | CN1476536A System for electro physiological measurements |
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/12/2004 | WO2004013609A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2004013608A2 Methods for eliminating false data from comparative data matrices and for quantifying data matrix quality |
| 02/12/2004 | WO2004013605A2 Nanoparticles comprising a mixed monolayer for specific ligand binding |
| 02/12/2004 | WO2004013604A2 Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays |
| 02/12/2004 | WO2004013602A2 Combined chemical/biological agent detection system and method utilizing mass spectrometry |
| 02/12/2004 | WO2004013601A2 A method to quantitatively analyze conjugated dienes in hydrocarbon feeds and products as an indicator of fouling potential |
| 02/12/2004 | WO2004012855A2 Ethylene glycol monolayer protected nanoparticles |
| 02/12/2004 | WO2004012588A2 Use of biomarkers for detecting ovarian cancer |
| 02/12/2004 | WO2003054513B1 Centrifugal array processing device |
| 02/12/2004 | US20040029287 Selective and rapid room temperature derivatization of conjugated dienes by 4- methyl-1, 2, 4-triazoline-3, 5-dione (MTAD) followed by Chemical ionization GC/MS and GC/NCD analyses |
| 02/12/2004 | US20040029205 By a test strip or stick assay, or other similar assays, for detecting the presence of leukocyte esterase which correlates to the presence of sputum; analysis to determine the presence of respiratory pathogens associated with pulmonary diseases |
| 02/12/2004 | US20040028561 Biological warfare; accumulation, confining, filtration, separation |
| 02/12/2004 | CA2494033A1 Novel procedure for growth, imaging, and enumeration of microbial colonies for serological or screening assays |
| 02/12/2004 | CA2493817A1 Use of biomarkers for detecting ovarian cancer |
| 02/05/2004 | WO2004011906A2 Diagnostic system for differentiating sputum from saliva |
| 02/05/2004 | WO2004011905A2 Quality assurance/quality control for electrospray ionization processes |
| 02/05/2004 | WO2004011904A2 Quality assurance for high-throughput bioassay methods |
| 02/05/2004 | WO2004011903A2 Monitoring molecular interactions using photon arrival-time interval distribution analysis |
| 02/05/2004 | WO2004011902A2 Improved systems and methods for analysis of protein post-translational modification |
| 02/05/2004 | WO2004011901A2 Electrodes and related devices |
| 02/05/2004 | WO2004011900A2 Detecting receptor oligomerization |
| 02/05/2004 | WO2004011664A2 Protein or carbohydrate profiling |
| 02/05/2004 | WO2003083442A3 Life sciences business systems and methods |
| 02/05/2004 | WO2003076895A3 Method and system for determining genotype from phenotype |
| 02/05/2004 | US20040023371 Sample block apparatus and method for maintaining a microcard on a sample block |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | US20040023303 Two- or three-dimensional polymeric or extended solid arrays, such as arrays of polydiacetylene backbone, are used to evaluate organic/water partition coefficient or absorptivity or permeability of compound by fluorescence change |
| 02/05/2004 | CA2493798A1 Improved systems and methods for analysis of protein post-translational modification |
| 01/29/2004 | WO2004010108A2 Method for the identification of ligands |
| 01/29/2004 | WO2004010107A2 Method for determining the regulation of xenobiotic removal |
| 01/29/2004 | WO2004010106A2 METHODS FOR IDENTIFYING SMALL MOLEDULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY |
| 01/29/2004 | WO2004010103A2 Impedance based devices and methods for use in assays |
| 01/29/2004 | WO2004010102A2 Impedance based apparatuses and methods for analyzing cells and particles |
| 01/29/2004 | US20040018430 Overcoating electrode particles with electroconductive coating of fluoropolymer |
| 01/29/2004 | CA2493808A1 Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mrna decay |
| 01/29/2004 | CA2491468A1 Method for the identification of ligands |
| 01/29/2004 | CA2491458A1 Method for determining the regulation of xenobiotic removal |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/22/2004 | WO2004008105A2 Detection of ligand/antiligand complex formation by electromagnetically detectable bulk property measurement |
| 01/22/2004 | WO2003073071A3 Device and method for determining and detecting the onset of structural collapse |
| 01/22/2004 | US20040014071 Non-radioactive markers that facilitate the detection and analysis of nascent proteins translated within cellular or cell-free systems; preferred markers are dipyrrometheneboron difluoride |
| 01/22/2004 | US20040014045 Detection of ligand/antiligand complex formation by electromagnetically detectable bulk property measurement |
| 01/22/2004 | US20040011643 Electrode |
| 01/15/2004 | WO2004005889A2 Detection of drug-resistant human immunodeficiency virus |
| 01/15/2004 | WO2004005884A2 Method and apparatus for molecular mechanics analysis of molecular systems |
| 01/15/2004 | US20040010525 Method and apparatus for molecular mechanics analysis of molecular systems |
| 01/15/2004 | US20040009554 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 01/15/2004 | US20040009124 Detection of drug-resistant human immunodeficiency virus |
| 01/15/2004 | US20040007675 Multi-dimensional fluorescence apparatus and method for rapid and highly sensitive quantitative analysis of mixtures |
| 01/15/2004 | CA2492040A1 Method and apparatus for molecular mechanics analysis of molecular systems |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/08/2004 | WO2004003514A2 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | WO2004003513A2 Compositions and methods for determining the replication capacity of a pathogenic virus |